CELL PROLIFERAT 润色咨询

CELL PROLIFERATION

出版年份:1991 年文章数:930 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:6.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-08-02 1273755368_54435992

    审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗

    23

    展开23条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2022-08-07 COCO-么么哒

    2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-05-09 suguoqing.my265

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤生物学
    经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的

    14

    展开14条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2023-09-19 ms8000000172957012 来自香港

    偏重的研究方向:发育
    经验分享:投稿的友友们,
    我是9.17 投稿
    9.18 分配编辑
    9.19 Under review
    我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~

    11

    展开11条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2023-04-18 ms5000000525855900 来自江苏省

    审稿速度:6.0 | 投稿命中率:75.0
    经验分享:4个月接收,速度还行。稿费贵了点

    11

    展开11条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-08-14 ms2401121251658649

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;增殖
    经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~

    11

    展开11条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-08-29 1245e6c8m84暂无昵称

    投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?

    11

    展开11条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-06-14 禾七木

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收

    9

    展开9条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-05-23 禾七木

    审稿速度:1.0
    经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?

    9

    展开9条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=805817, encodeId=966880581e58, content=审稿 underreview 半个月,,然后 awaiting reviewer assignment 一周了 怎么慢了,有同样遇到的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab4b2396493, createdName=1273755368_54435992, createdTime=Sun Aug 02 22:13:16 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿,不知为何,5月才开始外审, 6.3通知Major revision,6.20修回,7.14通知Minor revision,7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963868, encodeId=1f4596386868, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤生物学<br>经验分享:4.8 投稿,awaiting ADM processing 4.9 under review 4.10 awaiting reviewer assignment 4.25 awating reviewer scores 5.1 awating editor decision 5.2 awaiting EIC decision 5.3 minor revision 5.5 修回 5.8 under review,awaiting reviewer assignment,小修也需要外审的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Sun May 09 07:02:55 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向:发育<br>经验分享:投稿的友友们,<br>我是9.17 投稿 <br>9.18 分配编辑 <br>9.19 Under review <br>我想问一下Under review 不属于外审,是期刊内部评审,意思是主编那关已经过了吗?送外审的可能性大嘛 有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2126690, encodeId=7b6a2126690ae, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:4个月接收,速度还行。稿费贵了点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82618491364, createdName=ms5000000525855900, createdTime=Tue Apr 18 10:22:45 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=808928, encodeId=3b3680892857, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;增殖<br>经验分享:2020.7.1投稿,7.28小修返回,8.5修回,8.11接收!后续工作还在进行中...预祝各位百发百中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fvM2V9lKibssFhUpV5K7Ybx5oqiaJqIAIfiawvfOr6184hwpvtG3JIxfX1icicAn3utGNLhibO0NwW8LL6vl91T4PfLQ/132, createdBy=abca5353385, createdName=ms2401121251658649, createdTime=Fri Aug 14 16:54:50 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=880548, encodeId=7f44880548d7, content=投稿后说内容有问题,退回修改,但是再次上传后,就说手稿类型缺失,怎么也提交不了,大家遇到过这种情况吗?怎么破?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bfdc2482087, createdName=1245e6c8m84暂无昵称, createdTime=Sat Aug 29 08:21:57 CST 2020, time=2020-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602262, encodeId=de9f6022620b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:综述。4.17 submit,第二天分配编辑,4.20 under review,中间状态在等待审稿人评分和等待编辑决定之间变化了两次(有同学说是因为每有一个审稿人意见回来都会变为awaiting editor decision),5.20收到大修,三个审稿人每个都有很详细的修改意见,6.02修回,6.08接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sun Jun 14 21:18:39 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600253, encodeId=9fbb60025303, content=审稿速度:1.0<br>经验分享:4.17投稿一篇综述,5.20收到大修。但是主编没有给具体时限,只说“Because we are trying to facilitate timely publication of manuscripts submitted to Cell Proliferation, your revised manuscript should be uploaded as soon as possible.” 求问各位战友,这种情况下一般最长可以修多久啊?还有这个timely publication是模板还是证明修改后被接收的可能性比较大呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200523/29bf692d8cb4460c8321a9b66fb6a5c2/005vBqBbgy1fllxakhv4cj30ci0ciglo.jpg, createdBy=5ac75201695, createdName=禾七木, createdTime=Sat May 23 19:21:49 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908880, encodeId=88ba90888031, content=中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Thu Dec 17 17:00:23 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-12-17 1215c911m91暂无昵称

    中午投稿,下午就被拒了!确实是真快!秒拒。数据很多,创新也有,不愿意投cr,因为cr慢。就是因为感觉这个杂志会快,谁知道秒拒,真没劲。

    7

    展开7条回复
共427条页码: 1/43页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分